< Back to News

HOCOMA LAUNCHES THE WORLD’S FIRST COMMERCIALLY AVAILABLE ROBOTIC ARM EXOSKELETON FOR NEUROREHABILITATION

5th October 2011

After being the first to release a robotic gait orthosis in 2001, the Swiss medical technology company Hocoma now presents the world’s first commercially available robotic arm exoskeleton. As a part of the established Armeo® Therapy Concept, the ArmeoPower was designed for severely affected individuals who have suffered neurological disorders resulting in hand and arm impairment. The ArmeoPower provides an assist-as-needed support in an extensive 3D workspace and a virtual reality exercise environment for a higher patient motivation. The ArmeoPower will further expand Hocoma’s market leadership in robotic rehabilitation therapy.